Benhexyphenidyl hydrochloride tablets

The main ingredient of this product is trihexyphenidyl hydrochloride. Chemical name: (±)-α-cyclohexyl-α-phenyl-1-piperidinylpropanol hydrochloride Molecular weight: C20H31NO·HCl

This product is white tablets.

Oral: Parkinson's disease and Parkinson's syndrome, start with 1/2 to 1 tablet a day, and then increase by 1 tablet every 3 to 5 days until the best effect is achieved without side effects. Generally, no more than 5 tablets a day, divided into 3 to 4 times, must be taken for a long time. The maximum daily dose is 10 tablets. Drug-induced extrapyramidal disorders, 1 to 2 tablets on the first day, divided into 2 to 3 times, and then gradually increase to 2.5 to 5 tablets according to needs and tolerance. Elderly patients should reduce the dose as appropriate.

Common symptoms include dry mouth, blurred vision, etc., and occasionally tachycardia, nausea, vomiting, urinary retention, constipation, etc. Long-term use may cause drowsiness, depression, memory loss, hallucinations, and clouded consciousness.

Patients with glaucoma, urinary retention, and prostatic hypertrophy.

Precautions for children: Use with caution. Precautions for pregnancy and lactation: Use with caution. Precautions for the elderly: Long-term use in the elderly is likely to induce glaucoma. People with arteriosclerosis are prone to mental confusion, disorientation, anxiety, hallucinations and psychotic symptoms when taking the commonly used doses of anti-Parkinson's disease drugs. Use with caution.

1. When this product is used in combination with ethanol or other central nervous system depressants, the central inhibitory effect can be enhanced. 2. When this product is used in combination with adamantane, anticholinergic drugs, monoamine oxidase inhibitors pargyline and procarbazine, the anticholinergic effect can be enhanced and paralytic ileus may occur. 3. When this product is used in combination with monoamine oxidase inhibitors, it can lead to hypertension. 4. When this product is used in combination with antacids or adsorbent antidiarrheal agents, the effect of this product can be weakened. 5. When this product is used in combination with chlorpromazine, the latter's metabolism is accelerated, which can reduce its blood drug concentration. 6. When this product is used in combination with cardiac glycosides, the latter can prolong their residence time in the gastrointestinal tract, increase absorption, and be prone to poisoning.

seal.

2mg*100s

24 months

Tianjin Lisheng Pharmaceutical Co., Ltd.

• Founded in:

  1981-06-17

• Address:

  No. 16, Saida North 1st Road, Xiqing Economic Development Zone, Tianjin

• Tax NO.:

  91120000103069502J

• Registered Funds:

  257.942988 yuan

• Website:

  Log in to view

• Email:

  Log in to view